Title : Isoform-Selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury Via Mitochondrial Protection Through the HDACs/CREB/PGC-1α Signaling Pathway.

Pub. Date : 2022 Feb 1

PMID : 34983914






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Isoform-selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury via Mitochondrial Protection through the HDACs/CREB/PGC-1alpha Signaling Pathway. mocetinostat PPARG coactivator 1 alpha Homo sapiens
2 Isoform-selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury via Mitochondrial Protection through the HDACs/CREB/PGC-1alpha Signaling Pathway. mocetinostat PPARG coactivator 1 alpha Homo sapiens
3 Mocetinostat (MGCD0103) can protect myocardium from ischemia/reperfusion injury through mitochondrial protection mediated by CREB/PGC-1alpha pathway. mocetinostat PPARG coactivator 1 alpha Homo sapiens
4 Mocetinostat (MGCD0103) can protect myocardium from ischemia/reperfusion injury through mitochondrial protection mediated by CREB/PGC-1alpha pathway. mocetinostat PPARG coactivator 1 alpha Homo sapiens